CN Patent

CN107382952B — 埃格列净的制备方法及其中间体

Assigned to Shandong Kechao Biopharmaceutical Co Ltd · Expires 2020-02-28 · 6y expired

What this patent protects

本发明提供了一种制备埃格列净的合成方法，该路线涉及到新中间体化合物3和化合物5，通过该新中间体化合物3和化合物5制备得到SGLT‑2抑制剂埃格列净，该制备方法工艺路线简单、成本低廉、适宜工业化生产。

USPTO Abstract

本发明提供了一种制备埃格列净的合成方法，该路线涉及到新中间体化合物3和化合物5，通过该新中间体化合物3和化合物5制备得到SGLT‑2抑制剂埃格列净，该制备方法工艺路线简单、成本低廉、适宜工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN107382952B
Jurisdiction
CN
Classification
—
Expires
2020-02-28
Drug substance claim
No
Drug product claim
No
Assignee
Shandong Kechao Biopharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.